Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Tufia C HaddadJun HeCiara C O'SullivanBeiyun ChenDonald NorthfeltAmylou C DueckKarla V BallmanKathleen S TennerHannah LindenJoseph A SparanoJudith O HopkinsChamath De SilvaEdith A PerezPaul HaluskaMatthew P GoetzPublished in: Breast cancer research and treatment (2021)
ClinicalTrials.gov Identifier: NCT00684983.